Policies

We apply institutional policies and procedures.

Suggested wording for acknowledgement in publications where results have been obtained with our resources and/or services:

“We are grateful to the CRBIP unit CIP/PCC/CHIP, for providing fit-for-purpose biological resources and associated services”

Data Protection policy

We follow data protection policies of Institut Pasteur

Nagoya Protocol

We do due diligence for all prospectively acquired strains. We provide all available information, for both prospectively acquired and historical strains, to end users of microbial strains. We do not consider genomic data of strains to be in the scope of Nagoya Protocol, except if the country of origin’s ABS regulations explicitly state otherwise. We consider isolated strains only, and not primary human specimens (e.g. fecal samples), to be in the scope of NP. Human-origin specimens are not considered to be in the scope of NP, even if they may contain molecules, such as antibodies, that are produced as a specific immune response to a microorganism.

Regulatory Compliance Policy concerning collections of biological resources of human origin

Our Project Management Office takes care of all declaration and authorization procedures according to national regulations. This includes a "Transparency Portal" with short information about research projects that have made use of collections from CHIP. Description of other projects can be found here or here.

Gender Equality

We follow the Gender Equality Plan of Institut Pasteur. The CRBIP Director and three of the four Heads of Units are women.